🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.

Several experts said the popularity for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking fines, legal action or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the platform has taken down violative material and banned associated hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Online Trading Activities

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at residence.

Within minutes of entering one group, a vendor shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Product Information and Pricing

Inside these communities, messages display dark colored packages with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how much time a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has previously seen patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to possibly significant medical dangers”.